Pharmacokinetics of single dose intravenous infusion of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment | Journal of Shanghai Jiaotong University(Medical Science);(6)2006. | WPRIM

Conteúdo principal 1 Busca 2 Rodapé 3

+A A -A Alto contraste

Pharmacokinetics of single dose intravenous infusion of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment / 上海第二医科大学学报

xiao-dong, YAO; jin-fang, SHEN; yi-min, MAO; min-de, ZENG.

Journal of Shanghai Jiaotong University(Medical Science) ; (6)2006.

Artigo em Chinês | WPRIM | ID: wpr-640830

ABSTRACT

ABSTRACT

0.05). Conclusion The elimination half-life of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment is 27 h,and the regiment of 100 mg once a day is recommended.

magnesium isoglycyrrhizinate; pharmacokinetics; chronic hepatic impairment; intravenous infusion

Buscar no Google

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Journal of Shanghai Jiaotong University(Medical Science) Ano de publicação: 2006 Tipo de documento: Artigo

Similares

MEDLINE

LILACS

LIS

Buscar no Google

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Journal of Shanghai Jiaotong University(Medical Science) Ano de publicação: 2006 Tipo de documento: Artigo